In line with these results, we observed that ASP treatment inhibited cell adhesion and invasion in a dose-dependent manner in serous OC cells and reduced VEGF levels in the serum and ovarian tumors of KpB mice. This evidence concerns the gene VEGFA and ovarian neoplasm.